Ultralife Corporation (NASDAQ:ULBI) Q3 2022 Earnings Conference Call October 27, 2022 8:30 AM ET
Company Participants
Jody Burfening - Investor Relations
Michael Popielec - President and Chief Executive Officer
Philip Fain - Chief Financial Officer
Conference Call Participants
Josh Sullivan - The Benchmark Company, LLC
Operator
Hello and welcome to Ultralife Corporation Third Quarter 2022 Earnings Release. My name is Pricilla and I will be your coordinator for today's event. Please note this call is being recorded and your lines will be in listen-only, however you will have the opportunity to ask questions at the end during the Q&A session. [Operator Instructions]
I will now hand over to your host to Ms. Jody Burfening to begin today's conference. Thank you.
Jody Burfening
Thank you, and good morning, everyone, and thank you for joining us this morning for Ultralife Corporation's earnings conference call for the third quarter of fiscal 2022. We apologize for the delay in starting today's call, which occurred due to issues experienced by the conference call provider. So with us on today's call are Mike Popielec, Ultra's President and CEO; and Phil Fain, Ultralife's Chief Financial Officer.
The earnings press release was issued earlier this morning. If anyone has not yet received a copy, I invite you to visit the company's website, www.ultralifecorp.com, where you'll find the release under Investor News in the Investor Relations section.
Before turning the call over to management, I would like to remind everyone that some statements made during this conference call contain forward-looking statements based on current expectations.
Actual results could differ materially from those projected as a result of various risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include the impact of COVID-19 and related supply chain disruptions, potential reductions in revenues from key customers, acceptance of new products on a global basis and uncertain global economic conditions.
The company cautions investors not to place undue reliance on forward-looking statements, which reflect the company's analysis only as of today's date. The company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these and other factors that could affect Ultralife's financial results is included in Ultralife's filings with the Securities and Exchange Commission, including the latest Annual Report on Form 10-K.
In addition, on today's call, management will refer to certain non-GAAP financial measures that management considers to be useful metrics and differ from GAAP. These non-GAAP measures should be considered as supplemental to corresponding GAAP figures.